Stereotactic body radiotherapy for lung tumors in patients with subclinical interstitial lung disease: The potential risk of extensive radiation pneumonitis

Lung Cancer

Volumn 82, Issue 2, 2013, Pages 260-265

  Yamaguchi, Shinsaku ^a   Ohguri, Takayuki ^a   Ide, Satoru ^a   Aoki, Takatoshi ^a   Imada, Hajime ^b   Yahara, Katsuya ^a   Narisada, Hiroyuki ^b   Korogi, Yukunori ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b Tobata Kyoritsu Hospital   (Japan)

Author keywords

Bronchoalveolar lavage; Computed tomography; Interstitial lung disease; Lung cancer; Radiation pneumonitis; Stereotactic body radiotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG LAVAGE; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION PNEUMONIA; STEREOTACTIC BODY RADIATION THERAPY; THORAX RADIOGRAPHY;

BRONCHOALVEOLAR LAVAGE; COMPUTED TOMOGRAPHY; INTERSTITIAL LUNG DISEASE; LUNG CANCER; RADIATION PNEUMONITIS; STEREOTACTIC BODY RADIOTHERAPY;

AGED; AGED, 80 AND OVER; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIATION PNEUMONITIS; RADIOSURGERY; RADIOTHERAPY DOSAGE; RISK FACTORS; TUMOR BURDEN;

EID: 84887022754     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2013.08.024     Document Type: Article

References (27)

1. Jin H., Tucker S.L., Liu H.H., et al. Dose-volume thresholds and smoking status for the risk of treatment-related pneumonitis in inoperable non-small cell lung cancer treated with definitive radiotherapy. Radiother Oncol 2009, 91:427-432.
2. Guckenberger M., Baier K., Polat B., et al. Dose-response relationship for radiation-induced pneumonitis after pulmonary stereotactic body radiotherapy. Radiother Oncol 2010, 97:65-70.
3. Raghu G., Mageto Y.N., Lockhart D., Schmidt R.A., Wood D.E., Godwin J.D. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other interstitial lung disease: a prospective study. Chest 1999, 116:1168-1174.
4. Washko G.R., Hunninghake G.M., Fernandez I.E., et al. Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med 2011, 364:897-906.
5. Hanibuchi M., Yamaguchi T., Okada T., et al. Clinical examination of acute exacerbation of idiopathic interstitial pneumonia (IIP) combined with lung cancer after anti-cancer treatment. Jpn J Lung Cancer 2001, 41:281-286.
6. Takenaka K., Yoshimura A., Okano T., et al. Acute exacerbation of idiopathic interstitial pneumonia complicated by lung cancer, caused by treatment for lung cancer. Jpn J Lung Cancer 1999, 39:955-962.
7. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 2005, 63:1427-1431.
8. Yamashita H., Kobayashi-Shibata S., Terahara A., et al. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy. Radiat Oncol 2010, 5:32.
9. Onishi H., Marino K., Terahara A., et al. Case series study of 26 patients who developed fatal radiation pneumonitis (RP) after stereotactic body radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys 2009, 75:S62.
10. Takeda A., Enomoto T., Sanuki N., et al. Acute exacerbation of subclinical idiopathic pulmonary fibrosis triggered by hypofractionated stereotactic body radiotherapy in a patient with primary lung cancer and slightly focal honeycombing. Radiat Med 2008, 26:504-507.
11. Mizuguchi S., Nishiyama N., Iwata T., et al. Serum Sialyl Lewis x and cytokeratin 19 fragment as predictive factors for recurrence in patients with stage I non-small cell lung cancer. Lung Cancer 2007, 58:369-375.
12. Nisman B., Biran H., Ramu N., Heching N., Barak V., Peretz T. The diagnostic and prognostic value of ProGRP in lung cancer. Anticancer Res 2009, 29:4827-4832.
13. Washko G.R., Lynch D.A., Matsuoka S., et al. Identification of early interstitial lung disease in smokers from the COPDGene study. Acad Radiol 2010, 17:48-53.
14. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2:S94-S100.
15. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
16. Yamashita H., Nakagawa K., Nakamura N., et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat Oncol 2007, 2:21.
17. Borst G.R., Ishikawa M., Nijkamp J., et al. Radiation pneumonitis in patients treated for malignant pulmonary lesions with hypofractionated radiation therapy. Radiother Oncol 2009, 91:307-313.
18. Matsuo Y., Shibuya K., Nakamura M., et al. Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys 2012, 83:e545-e549.
19. Barriger R.B., Forquer J.A., Brabham J.G., et al. A dose-volume analysis of radiation pneumonitis in non-small cell lung cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2012, 82:457-462.
20. Kawabata Y., Fukushima K., Uchiyama T., Sugita H., Kimura B. [A focal usual interstitial pneumonia lesion: an important risk factor in diffuse alveolar damage--acute exacerbation of a focal usual interstitial pneumonia patient]. Nihon Kokyuki Gakkai Zasshi 2001, 39:316-321.
21. Gibson P.G., Bryant D.H., Morgan G.W., et al. Radiation-induced lung injury: a hypersensitivity pneumonitis. Ann Intern Med 1988, 109:288-291.
22. Smith J.C. Radiation pneumonitis case report of bilateral reaction after unilaternal irradiation. Am Rev Respir Dis 1964, 89:264-269.
23. Morgan G.W., Breit S.N. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys 1995, 31:361-369.
24. Roberts C.M., Foulcher E., Zaunders J.J., et al. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med 1993, 118:696-700.
25. Tsujino K., Hirota S., Kotani Y., et al. Radiation pneumonitis following concurrent accelerated hyperfractionated radiotherapy and chemotherapy for limited-stage small-cell lung cancer: dose-volume histogram analysis and comparison with conventional chemoradiation. Int J Radiat Oncol Biol Phys 2006, 64:1100-1105.
26. Rancati T., Ceresoli G.L., Gagliardi G., Schipani S., Cattaneo G.M. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003, 67:275-283.
27. Kimura T., Matsuura K., Murakami Y., et al. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers. Int J Radiat Oncol Biol Phys 2006, 66:483-491.